NephroGenex, Inc. Clinical Trials
Studies registered on ClinicalTrials.gov (U.S. National Library of Medicine) with the company as lead sponsor or collaborator, newest start first. Values are as registered.
- 2014-06: Study NCT02156843; Company role Lead sponsor; Phase Phase 3; Status Terminated.
- 2008-08: Study NCT00734253; Company role Lead sponsor; Phase Phase 2; Status Completed.
| Start date | Study | Company role | Phase | Status | Conditions | Enrollment | Completion date |
|---|---|---|---|---|---|---|---|
| 2014-06 | NCT02156843 Pyridorin in Diabetic Nephropathy | Lead sponsor | Phase 3 | Terminated | Diabetic Nephropathy; Diabetic Kidney Disease | 328 | 2018-03 |
| 2008-08 | NCT00734253 Safety and Efficacy Study of Pyridorin in Patients With Nephropathy Due to Type 2 Diabetes | Lead sponsor | Phase 2 | Completed | Diabetic Nephropathy | 317 | 2010-08 |